A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older
Clinical trial NCT01222403 · COMPLETED
Trial details
- NCT number
- NCT01222403
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-10-01
- Enrollment
- 767
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.